Dias da Costa Tiago, Rodrigues Marta, Mateus-Pinheiro António, Moreira Sónia
Internal Medicine Department, Unidade Local de Saúde de Coimbra, Coimbra, Portugal.
Radiology Department, Hospital da Luz, Aveiro, Portugal.
Eur J Case Rep Intern Med. 2025 Mar 28;12(4):005325. doi: 10.12890/2025_005325. eCollection 2025.
Anoctamin-5 (ANO5) muscular dystrophy is a rare neuromuscular disease. Muscular weakness and impaired gait may be evident at the moment of diagnosis, serving as defining characteristics of additional muscular dystrophies. Rhabdomyolysis, on the other hand, is a rare presentation Understanding this phenotype is of great importance since it can go unnoticed by physicians, leading to misdiagnosis of metabolic myopathies or delayed diagnosis. We discuss a case of recurrent rhabdomyolysis due to ANO5 muscular dystrophy.
A 34-year-old man was referred to our Reference Centre for Hereditary and Metabolic Diseases due to incidentally elevated creatine kinase levels of 4369 U/l (normal value: < 171 U/l) in the context of acute renal colic. He described a 10-year history of progressive myalgia induced by physical activity, particularly in the lower extremities, muscle spasms, and sporadic reddish to brown urine. Although no muscle weakness was detected upon neurological examination, bilateral calf hypertrophy was noted. A comprehensive laboratory analysis was conducted to exclude acquired causes of rhabdomyolysis, including electrolyte abnormalities, endocrine disruptions, and autoimmune myopathies. Considering the high suspicion of an inherited aetiology, we proceeded with next-generation sequencing of rhabdomyolysis-related genes. Genetic testing revealed a c.1180+6t>Cp homozygous mutation in ANO5 gene, which confirmed anoctamin-5 muscular dystrophy.
ANO5 muscular dystrophy is a rare cause of inherited rhabdomyolysis. Understanding this phenotype is crucial for accurate and timely diagnosis. Currently, there is no specific treatment for this condition, but management should include avoiding heavy muscle training and use of statins.
Anoctamin-5 (ANO5) muscular dystrophy is a rare neuromuscular disease originated by homozygous mutations in ANO5, a gene encoding a protein with the same name located on chromosome 11. ANO5 is a calcium-activated chloride channel that is highly expressed in heart and skeletal muscle. It is a rare cause of inherited rhabdomyolysis. Understanding this phenotype is crucial for accurate and timely diagnosis.We must emphasize how meticulous medical history taking along with a high index of suspicion are essential to diagnose this disease.Currently, there is no specific treatment for this condition, but management should include avoiding heavy muscle training and use of statins.
anoctamin - 5(ANO5)型肌营养不良症是一种罕见的神经肌肉疾病。在诊断时,肌无力和步态障碍可能很明显,这也是其他肌营养不良症的典型特征。另一方面,横纹肌溶解症是一种罕见的表现形式。了解这种表型非常重要,因为医生可能会忽视它,从而导致代谢性肌病的误诊或诊断延迟。我们讨论一例因ANO5型肌营养不良症导致的复发性横纹肌溶解症病例。
一名34岁男性因急性肾绞痛时偶然发现肌酸激酶水平升高至4369 U/l(正常值:<171 U/l)被转诊至我们的遗传性和代谢性疾病参考中心。他描述有10年因体力活动诱发的进行性肌痛病史,尤其是下肢,伴有肌肉痉挛以及偶发的淡红色至棕色尿液。尽管神经检查未发现肌无力,但双侧小腿出现肥大。进行了全面的实验室分析以排除横纹肌溶解症的后天性病因,包括电解质异常、内分泌紊乱和自身免疫性肌病。鉴于高度怀疑为遗传性病因,我们对与横纹肌溶解症相关的基因进行了二代测序。基因检测显示ANO5基因存在c.1180 + 6t>Cp纯合突变,确诊为anoctamin - 5型肌营养不良症。
ANO5型肌营养不良症是遗传性横纹肌溶解症的罕见病因。了解这种表型对于准确及时的诊断至关重要。目前,针对这种病症尚无特效治疗方法,但管理措施应包括避免高强度肌肉训练和使用他汀类药物。
anoctamin - 5(ANO5)型肌营养不良症是一种罕见的神经肌肉疾病,由ANO5基因的纯合突变引起,ANO5基因位于11号染色体上,编码一种同名蛋白质。ANO5是一种钙激活氯通道,在心脏和骨骼肌中高度表达。它是遗传性横纹肌溶解症的罕见病因。了解这种表型对于准确及时的诊断至关重要。我们必须强调,详细的病史采集以及高度的怀疑指数对于诊断这种疾病至关重要。目前针对这种病症尚无特效治疗方法,但管理措施应包括避免高强度肌肉训练和使用他汀类药物。